Skip to main content

Alexander J. Civetta


[email protected]



Alex is a corporate and commercial contracts attorney who advises companies on the intersection of law and business, with an emphasis on technology transactions, licensing, and negotiation. He regularly handles licensing agreements, intellectual property–related agreements, and other transactions — including equity transactions and a wide variety of commercial contracts — for innovators in the software, technology, professional services, and biotechnology industries. Alex also advises private companies of all sizes on strategic corporate matters.

Prior to joining Mintz, Alex was a senior associate in the Boston office of a large, international law firm, where he drafted and negotiated licensing agreements and commercial contracts and advised clients in general corporate matters and equity transactions. His technology sector experience includes drafting and negotiating software-as-a-service agreements, software licenses, data licenses, trademark licenses, joint development and commercialization agreements, whitelabeling agreements, reseller and distributor agreements, data exchange agreements (domestic and cross-border), co-branding and co-promotion agreements, terms of service and terms of sale, services agreements, and multi-step intellectual property restructurings. For biotechnology clients, Alex has drafted and negotiated collaboration agreements, patent license agreements, settlement agreements, research services agreements, and manufacture and supply agreements.

Alex is particularly focused on using interest-based negotiation to get the best possible results for his clients.  He was previously a teaching assistant for negotiation courses at Harvard Law School, the Massachusetts Institute of Technology’s Sloan School of Management, and various executive education programs through Harvard’s Program on Negotiation. He also served as managing editor of the Harvard Negotiation Law Review. Alex facilitates negotiation trainings and workshops for companies and other institutions on a consulting basis and teaches workshops for the American Association of University Women’s “Work Smart” program, designed to help participants negotiate for new jobs, raises, and promotions.

Before Alex attended law school, he was a senior program manager at a private software-as-a-service company, where he advised clients on complex software integration projects.


  • Harvard University (JD, cum laude)
  • Yale University (BA, magna cum laude)

Recognition & Awards

  • Chambers USA: Start Ups and Emerging Companies (2022)
  • Massachusetts Supreme Judicial Court's Pro Bono Honor Roll (2021)
  • Boston Magazine Top Lawyers – Corporate Law (2021)

Recent Insights


News & Press



Viewpoint Thumbnail

Six Common Contract Traps: A Field Guide

March 25, 2022 | Advisory | By Alex Civetta

Read more
Viewpoint Thumbnail

Stock Vesting in Startup Companies

March 15, 2022 | Article | By Alex Civetta, Garrett Galvin

Building a company from the ground up is a risky endeavor for founders. In exchange for the founders’ efforts and devotion to the success of the company, the founders take a significant equity stake in the company, with the expectation that the value of these shares will grow substantially as the company grows.
Read more
Viewpoint Thumbnail

Enforcing Click-Through and URL Terms

March 30, 2021 | Advisory | By Alex Civetta, Kati P. Strzelczyk

Read about how companies can increase the enforceability of digital contracts, online terms incorporated by reference into non-electronic agreements, and updates of online terms.
Read more
Viewpoint Thumbnail

The Beauty and the Terror of Agile Software Development

March 24, 2021 | Advisory | By Alex Civetta, Garrett Galvin

This Mintz advisory reviews the challenges associated with agile software development contracts and provides best practices to avoid rising costs and legal disputes.
Read more

News & Press

Press Release Thumbnail
Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.


Guest Lecturer